Literature DB >> 19632395

Society of Thoracic Surgeons score is superior to the EuroSCORE determining mortality in high risk patients undergoing isolated aortic valve replacement.

Daniel Wendt1, Brigitte R Osswald, Katrin Kayser, Matthias Thielmann, Paschalis Tossios, Parwis Massoudy, Markus Kamler, Heinz Jakob.   

Abstract

BACKGROUND: Major scores for the evaluation of procedural risk in cardiac surgery are the European system for cardiac operative risk evaluation score (EuroSCORE), the Society of Thoracic Surgeons (STS) score, and the Parsonnet score. The aim of our study was to analyze the predictive value of these scores in "high risk" patients undergoing isolated aortic valve replacement (AVR).
METHODS: Six hundred and fifty-two patients underwent isolated AVR from January 1999 through June 2007. Emergency and redo operations were included; acute endocarditis was excluded. Evaluation was performed by logistic regression analysis. Data collection was prospective.
RESULTS: The mean logistic EuroSCORE of all patients was 8.5 +/- 7.9%, the mean STS score was 4.4 +/- 3.9%, and the mean logistic Parsonnet score was 9.8 +/- 8.5%. In-hospital mortality was 2.5% (n = 16). Freedom from all-cause death was 93.4% at 1 year, 90.2% at 2 years, and 75.8% at 5 years, respectively. A total of 182 patients had a logistic EuroSCORE greater than 10. For the group of patients with a EuroSCORE between 10% and 20% (n = 130) the mean EuroSCORE was 13.9 +/- 2.8% and the STS score was 6.5 +/- 3.8%. Observed mortality was 4.6% in this group. For the 52 patients with a logistic EuroSCORE of at least 20 (mean 28.5 +/- 10.3%, STS score 10.1 +/- 7.3%) the observed mortality was 3.9% (n = 2). By stepwise logistic regression, none of the EuroSCORE variables could be identified as an independent predictor in the "high- risk" group.
CONCLUSIONS: The logistic EuroSCORE was primarily created to allow patient grouping for the total spectrum of cardiac surgery. In patients undergoing isolated AVR, the EuroSCORE highly overestimates mortality, whereas the STS score seems to be actually more suitable in assessing perioperative mortality for these patients.

Entities:  

Mesh:

Year:  2009        PMID: 19632395     DOI: 10.1016/j.athoracsur.2009.04.059

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  29 in total

1.  Local versus general anesthesia for transfemoral aortic valve implantation.

Authors:  Lukas J Motloch; Dennis Rottlaender; Sara Reda; Robert Larbig; Marie Bruns; Jochen Müller-Ehmsen; Justus Strauch; Navid Madershahian; Erland Erdmann; Thorsten Wahlers; Uta C Hoppe
Journal:  Clin Res Cardiol       Date:  2011-09-20       Impact factor: 5.460

Review 2.  [Transcatheter aortic valve implantation : what do anesthetists need to know?].

Authors:  C Riediger; F Nietlispach; F Rüter; J Fassl
Journal:  Anaesthesist       Date:  2011-12       Impact factor: 1.041

Review 3.  [Transcatheter valve interventions for heart valve diseases].

Authors:  A Schaefer; H Bertram
Journal:  Internist (Berl)       Date:  2010-12       Impact factor: 0.743

4.  Comparison of multicenter registries and randomized control trials for transcatheter aortic valve replacement (TAVR).

Authors:  Shikhar Agarwal; E Murat Tuzcu; William Stewart; Navkaranbir Singh Bajaj; Lars G Svensson; Samir R Kapadia
Journal:  Indian Heart J       Date:  2013-07-10

5.  The revised EuroSCORE II for the prediction of mortality in patients undergoing transcatheter aortic valve implantation.

Authors:  Alexander Sedaghat; Jan-Malte Sinning; Mariuca Vasa-Nicotera; Alexander Ghanem; Christoph Hammerstingl; Eberhard Grube; Georg Nickenig; Nikos Werner
Journal:  Clin Res Cardiol       Date:  2013-07-23       Impact factor: 5.460

6.  Perspective on the cost-effectiveness of transapical aortic valve implantation in high-risk patients: Outcomes of a decision-analytic model.

Authors:  Hemal Gada; Shikhar Agarwal; Thomas H Marwick
Journal:  Ann Cardiothorac Surg       Date:  2012-07

7.  Aortic stenosis in high-risk patients. Surgical therapy.

Authors:  T Walther; M Arsalan; J Blumenstein; A van Linden; J Kempfert
Journal:  Herz       Date:  2013-03       Impact factor: 1.443

8.  Effect of gender on treatment and outcomes in severe aortic stenosis.

Authors:  Maryanne Hartzell; Rajeev Malhotra; Kibar Yared; Hannah R Rosenfield; Jennifer D Walker; Malissa J Wood
Journal:  Am J Cardiol       Date:  2011-03-26       Impact factor: 2.778

9.  Transcatheter aortic valve implantation in a patient with aplastic anemia.

Authors:  Yujiro Kawai; Yasuyuki Toyoda; Hikaru Kimura; Miki Horigome; Yasutoshi Tsuda; Takahiro Takemura
Journal:  J Cardiol Cases       Date:  2017-09-05

10.  Preoperative diastolic function predicts the onset of left ventricular dysfunction following aortic valve replacement in high-risk patients with aortic stenosis.

Authors:  Marc Licker; Mustafa Cikirikcioglu; Cidgem Inan; Vanessa Cartier; Afksendyios Kalangos; Thomas Theologou; Tiziano Cassina; John Diaper
Journal:  Crit Care       Date:  2010-06-03       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.